Related by context. All words. (Click for frequent words.) 75 radical nephrectomy 75 axillary lymph node dissection 73 lymphadenectomy 71 pneumonectomy 71 androgen deprivation 71 cytoreductive surgery 71 orchiectomy 71 lymph node dissection 70 oophorectomy 70 debulking surgery 70 cystectomy 70 nephrectomy 70 preoperative chemotherapy 70 pelvic lymphadenectomy 70 nephron sparing surgery 70 pCR 70 axillary dissection 70 adjuvant radiation 70 axillary node dissection 69 postoperative morbidity 69 cytoreduction 69 EBRT 69 curative resection 69 perioperative mortality 69 underwent resection 68 neoadjuvant therapy 68 nodal metastases 68 adjuvant radiotherapy 68 gastrectomy 68 salpingo oophorectomy 68 tumor resection 68 perioperative complications 68 distant metastases 68 adrenalectomy 68 advanced adenomas 68 bilateral oophorectomy 68 colectomy 68 R0 resection 68 sentinel node biopsy 68 FOLFOX4 67 esophagectomy 67 chemoradiation 67 lobectomy 67 micrometastases 67 tumor recurrence 67 liver resection 67 abdominal hysterectomy 67 cranial irradiation 67 radioiodine therapy 67 transurethral resection 67 chemoradiotherapy 67 SLNB 67 TURP 67 contralateral breast 67 postoperative chemotherapy 67 radical cystectomy 67 colorectal metastases 66 complete cytogenetic response 66 adenomatous polyps 66 neoadjuvant chemotherapy 66 chemoembolization 66 endarterectomy 66 Adjuvant chemotherapy 66 vaginal hysterectomy 66 TACE 66 thoracoscopic lobectomy 66 locoregional recurrence 66 bowel resection 66 placebo dexamethasone 66 total thyroidectomy 66 Radical prostatectomy 66 axillary node 66 sentinel lymph node biopsy 66 revascularization procedures 66 biochemical recurrence 66 parathyroidectomy 66 pT2 66 external beam radiotherapy 66 advanced adenoma 66 resectable 66 CR nPR 66 renal tumors 65 adjuvant chemotherapy 65 axillary nodes 65 pancreatic adenocarcinoma 65 orchidectomy 65 HBeAg seroconversion 65 node dissection 65 benign lesions 65 partial nephrectomy 65 chemoradiation therapy 65 intestinal metaplasia 65 post thrombotic syndrome 65 postoperative mortality 65 endometrial carcinoma 65 recurrent VTE 65 pulmonary metastases 65 resected 65 adjuvant therapy 65 adenoma 65 perioperative morbidity 65 biochemical relapse 65 HoLEP 65 PSADT 65 radical prostatectomy RP 65 liver metastases 65 Cystectomy 65 laparoscopically assisted 65 occlusive disease 65 infarct size 65 repigmentation 65 pT3 65 prostate TURP 65 β blockers 64 thromboembolic events 64 recurrent glioblastoma multiforme 64 adenotonsillectomy 64 nonoperative treatment 64 nonoperative 64 reoperation 64 MACCE 64 lung metastases 64 adenomatous 64 PSA nadir 64 thyroidectomy 64 adjuvant therapies 64 hepatectomy 64 breast carcinoma 64 endosonography 64 achieved ACR# 64 liver metastasis 64 peritoneal cancer 64 hepatic resection 64 pulmonary artery banding 64 fibrinolysis 64 Kaplan Meier analysis 64 histologically 64 colorectal carcinoma 64 angiographic restenosis 64 endometrial hyperplasia 64 thyroid nodules 64 NMIBC 64 IV NSCLC 64 histologically confirmed 64 surgical excision 64 ovariectomy 64 prostate cancer CRPC 64 CYPHER Stent 64 EUS FNA 64 axillary lymph nodes 64 radiotherapy RT 64 aromatase inhibitor therapy 64 thromboprophylaxis 64 hepatic metastases 64 Surgical resection 64 intraoperative complications 64 subtrochanteric 63 clodronate 63 corticosteroid therapy 63 PASI scores 63 CCyR 63 binary restenosis 63 OPCAB 63 5FU 63 operable breast cancer 63 palliation 63 stage IIIB 63 benign nodules 63 CsA 63 LVEF 63 Doxil ® 63 mutated K ras 63 unresectable tumors 63 patients undergoing CABG 63 GnRH agonists 63 epithelial ovarian 63 trabeculectomy 63 leiomyomas 63 F FDG PET 63 prostate carcinoma 63 pelvic lymph node dissection 63 androgen suppression 63 cytoreductive nephrectomy 63 atypical hyperplasia 63 neoadjuvant 63 oncologic outcomes 63 prostate cancer CaP 63 varices 63 carotid endarterectomy 63 sleeve lobectomy 63 neutropenic patients 63 invasive carcinoma 63 carotid stenosis 63 cytogenetic response 63 peritoneal carcinomatosis 63 complete cytogenetic 63 metastatic lesions 63 elective PCI 63 malignant neoplasm 63 amenorrhoea 63 underwent surgical resection 63 recanalization 63 nephrectomies 63 pancreatic resection 63 sentinel nodes 63 femoral shaft fracture 63 malignant polyps 63 malignant lesions 63 alteplase 63 adjuvant hormonal therapy 63 precursor lesions 63 postintervention 63 meniscectomy 63 radical retropubic prostatectomy 63 radiochemotherapy 63 Hurthle cell 63 Ishak fibrosis score 63 lymph node involvement 63 AVODART 63 tamsulosin 63 colon resection 63 MADRS score 63 nodal dissection 63 para aortic 63 preoperative radiotherapy 62 5-fluorouracil/leucovorin 62 asymptomatic carotid stenosis 62 resection 62 catheter angiography 62 reintervention 62 radical prostatectomy 62 CMV disease 62 axillary lymph node 62 luminal diameter 62 metastatic RCC 62 carboplatin paclitaxel 62 renal cell carcinomas 62 androgen suppression therapy 62 reimplantation 62 adenoidectomy 62 sacrocolpopexy 62 intravitreal injections 62 locoregional 62 intravesical therapy 62 tamoxifen therapy 62 lymph node removal 62 wedge resection 62 sustained virological response 62 postoperative radiotherapy 62 thromboembolic 62 intraoperative bleeding 62 definite stent thrombosis 62 mucosal healing 62 Free Survival PFS 62 Thal Dex 62 retroperitoneal 62 atrophic gastritis 62 enucleation 62 sUA 62 baseline LDH 62 UPPP 62 leiomyoma 62 spinal metastases 62 mycophenolate mofetil 62 metachronous 62 submandibular gland 62 HSCT 62 NATRECOR R 62 reoperations 62 CIN3 62 undetectable HBV DNA 62 micrometastasis 62 sustained virologic response 62 thymectomy 62 evaluable subjects 62 gastroesophageal junction 62 colorectal liver metastases 62 plain radiographs 62 hematologic toxicity 62 thoracotomy 62 lumbar spine BMD 62 detrusor overactivity 62 postoperative complications 62 core needle biopsy 62 paclitaxel eluting stents 62 flutamide 62 postoperative complication 62 total abdominal hysterectomy 62 clinically localized prostate 62 EDSS scores 62 GISTs 62 bilateral orchiectomy 62 dacarbazine 62 abciximab 62 locoregional disease 61 completely resected 61 nonmelanoma skin cancers 61 polyp recurrence 61 cerebral angiography 61 intermittent hemodialysis 61 HNSCC 61 lung metastasis 61 rebleeding 61 resections 61 reperfusion therapy 61 surgical debulking 61 undergoing radical prostatectomy 61 chemoresistant 61 upper gastrointestinal bleeding 61 nasal obstruction 61 biventricular repair 61 fundoplication 61 sentinel node 61 XELOX 61 graft occlusion 61 beta blocker therapy 61 secondary efficacy endpoint 61 mediastinal 61 relapsed SCLC 61 axilla 61 metastatic neuroendocrine tumors 61 #mg BID [001] 61 nodal metastasis 61 tirofiban 61 adenoma recurrence 61 androgen ablation 61 extrapleural pneumonectomy 61 malignant pleural mesothelioma 61 mediastinoscopy 61 fondaparinux 61 antithrombotic therapy 61 mitomycin C 61 contralateral breast cancer 61 revascularization procedure 61 polypoid lesions 61 FOLFOX 61 perioperatively 61 sympathectomy 61 myocardial viability 61 cystic lesions 61 median PFS 61 HIPEC 61 rosuvastatin #mg 61 coronary revascularization 61 systemic corticosteroids 61 lumbar disk herniation 61 hyperplastic 61 opioid analgesia 61 liver biopsies 61 prostatectomy 61 conventional angiography 61 octreotide LAR 61 Burch colposuspension 61 P = .# 61 CR CRu 61 histologic subtype 61 atheroma volume 61 cilostazol 61 HGPIN 61 Postoperatively 61 optical colonoscopy 61 distant metastasis 61 retransplantation 61 primary patency 61 aortic root replacement 61 fibrinolytic therapy 61 SLN biopsy 61 prior nephrectomy 61 FOLFOX6 61 stage IIIb IV 61 severe neutropenia 61 atherogenic dyslipidemia 61 endoscopic resection 61 hemorrhagic complications 61 SUVmax 61 oral anticoagulant therapy 61 CTEPH 61 elevated LDH 61 serum calcium levels 61 mg kg dose 61 osteosarcomas 61 donor nephrectomy 61 pericardial effusion 61 5-FU/LV 61 imipenem 61 #Gy 61 lymph node metastases 61 preoperatively 61 tumor shrinkage 61 fallopian tube carcinoma 61 pathologic diagnosis 61 allogeneic stem cell 61 pathologic fracture 61 hypogonadal 61 lobular carcinoma 61 recurrent NSCLC 61 cholecystectomy 61 reinfarction 61 gout flares 61 cytologically confirmed 60 Cardiopulmonary bypass 60 RYGB 60 neurologic complications 60 T1a 60 pamidronate 60 metastatic malignant melanoma 60 BRCA1 mutation carriers 60 lipid lowering therapy 60 squamous histology 60 tumor necrosis 60 virologic response 60 azoospermia 60 urothelial carcinoma 60 situ CIS 60 mRCC 60 MitraClip device 60 mL/min/#.# m 2 60 nonischemic cardiomyopathy 60 zoledronic acid 60 KRAS mutations occur 60 % CI #.#-#.# [007] 60 VUR 60 RALP 60 unresectable stage 60 hip resurfacing arthroplasty 60 transthoracic 60 repeat revascularization 60 endocrine therapies 60 LAGB 60 NSTE ACS 60 postoperatively 60 malignant growths 60 invasive coronary angiography 60 colorectal adenoma 60 incisional 60 periprocedural 60 peginterferon 60 antibiotic prophylaxis 60 HbA 1c levels 60 median sternotomy 60 lymph node metastasis 60 situ LCIS 60 variceal hemorrhage 60 LVRS 60 underwent radical prostatectomy 60 biliary tract cancer 60 VAD implantation 60 neoadjuvant treatment 60 stent implantation 60 IOP lowering 60 intravenous bisphosphonates 60 adjuvant tamoxifen 60 % CI #.#-#.# [003] 60 allogeneic SCT 60 total knee arthroplasty 60 cervical carcinoma 60 virological response 60 immunosuppressive medications 60 transplantation HCT 60 bypass grafting 60 neoplasia 60 everolimus eluting stents 60 oxycodone CR 60 KRAS mutations 60 HER2 negative 60 paroxysmal AF 60 thymoma 60 mucinous 60 androgen deprivation therapy 60 Operative mortality 60 liver histology 60 EXJADE 60 postprocedure 60 pulmonary resection 60 postoperative infections 60 nadolol 60 crossclamp 60 pegylated liposomal doxorubicin 60 oral anticoagulation 60 incomplete revascularization 60 LNG IUS 60 ipsilateral stroke 60 severe renal impairment 60 cisplatin vinorelbine 60 complete remissions 60 antimicrobial prophylaxis 60 TURBT 60 polypectomy 60 removed laparoscopically 60 TRUS biopsy 60 ipsilateral breast 60 endoscopic ultrasonography 60 adenocarcinomas 60 pleurodesis 60 IFN alfa 60 segmentectomy 60 revascularization 60 hypoperfusion 60 extracapsular extension 60 FOLPI 60 invasive carcinomas 60 medically inoperable 60 BRCA2 mutation carriers 60 colonography 60 biliopancreatic diversion 60 coronary arteriography 60 skeletal metastases 60 monoclonal gammopathy 60 adenomas 60 oral antidiabetic medication 60 paracentesis 60 mitral regurgitation 60 ximelagatran 60 neoplasias 60 skin sparing mastectomy 60 NNRTI resistance 60 invasive ductal 60 refractory ischemia 60 basal cell carcinoma BCC 60 histologic 60 risk reducing salpingo 60 Papillary 60 metastatic GIST 60 APTIVUS r 60 cytogenetic abnormalities 60 dysplastic 60 unresectable 60 tenecteplase 60 lung resection 60 neoadjuvant radiation 60 progression TTP 60 needle aspiration 60 FluCAM 60 fluorouracil 60 CMV infection 60 hypertrophic scars 60 variceal 60 myomectomy 60 pancreaticoduodenectomy 60 nephrotoxicity 60 breast carcinomas 60 postoperative atrial fibrillation 60 mitoxantrone 60 malignant neoplasms 60 comparator arm 60 lopinavir r arm 60 varicoceles 60 p = NS 60 liver transplant recipients 60 Natalizumab 60 plus methotrexate 60 plus MTX 60 postoperative bleeding 60 Gliadel Wafer 60 methotrexate monotherapy 60 Coronary artery bypass graft 60 renal transplantation 60 dalteparin 60 symptomatic fibroids 60 metastatic gastric 60 premalignant 60 Mitomycin C 60 adriamycin 59 TKAs 59 metastases 59 ASCUS 59 pancreatectomy 59 morphometric vertebral fractures 59 thromboembolism 59 GP IIb IIIa inhibitors 59 imatinib therapy 59 symptomatic carotid stenosis 59 HBeAg 59 myomas 59 symptomatic VTE 59 radiographic findings 59 ICD implantation 59 metastatic lung cancer 59 total knee arthroplasties 59 H. pylori eradication 59 annualized relapse 59 resected pancreatic cancer 59 helical CT 59 nonmetastatic 59 percutaneous intervention 59 cervical lymph nodes 59 nonfatal MI 59 revascularisation 59 grade dysplasia 59 decompressive surgery 59 chorioamnionitis 59 glycoprotein IIb IIIa inhibitors 59 OAB symptoms 59 mcg albinterferon alfa 2b 59 HER2 expression 59 VATS lobectomy 59 K ras mutations 59 grade cervical intraepithelial 59 gadolinium enhanced 59 fibroma 59 interferon ribavirin 59 chronic rhinosinusitis 59 oblimersen 59 endometrial thickness 59 hamartomas 59 gemcitabine Gemzar 59 undergone radical prostatectomy 59 FOLFIRINOX 59 clinicopathological features 59 undergoing hysterectomy 59 lobectomies 59 breast conserving 59 adnexal mass 59 hemoglobin A1c levels 59 patients undergoing noncardiac 59 ischemic cardiomyopathy 59 fistula closure 59 standard chemotherapy regimen 59 glycated hemoglobin levels 59 paragangliomas 59 denervation 59 ADPKD 59 lumbar disc herniation 59 femoral neck fractures 59 postop 59 arteriography 59 p = #.# [003] 59 serum phosphate 59 revascularizations 59 VT VF 59 Ebstein anomaly 59 Radiofrequency ablation 59 duplex ultrasonography 59 creatinine clearance 59 ACR# responses 59 sarcomatoid 59 PAOD 59 EBUS FNA 59 splenectomized 59 HBeAg positive patients 59 bladder carcinoma 59 Taxus Stent 59 femoral shaft fractures 59 CIMZIA ™ 59 colonoscopic 59 contrast induced nephropathy 59 node metastases 59 carotid endarterectomy CEA 59 ductal cancer 59 pelvic lymph nodes 59 EDSS score 59 PCa 59 moderate renal impairment 59 radial artery grafts 59 oral allopurinol 59 prognostic factors 59 RECIST Response Evaluation Criteria 59 response pCR 59 ACR# response 59 dose cytarabine 59 multivessel disease 59 cholelithiasis 59 sentinel lymph nodes 59 Median survival 59 DAPT 59 Elitek 59 anticoagulant therapy 59 azacitidine 59 diagnostic angiography 59 FOLFIRI 59 polyposis 59 mCRC patients 59 hematuria 59 supratentorial 59 lymphadenopathy 59 vertebroplasty 59 reintubation 59 transfemoral approach 59 partial remissions 59 tibolone 59 anticoagulation therapy 59 corticosteroid dose 59 metastatic prostate 59 nodular partial response 59 osteochondromas 59 GIST tumors 59 #.#ng/ml 59 pyelonephritis 59 GnRH agonist 59 vertebral fracture 59 prostate adenocarcinoma 59 transitional cell carcinoma 59 timepoint 59 allogeneic hematopoietic stem cell 59 excisional biopsy 59 HBeAg negative 59 metaplasia 59 peginterferon alfa 2a 59 venous reflux 59 chronic periodontitis 59 ovarian carcinoma 59 intracranial hemorrhage ICH 59 undergone hysterectomy 59 unfractionated heparin 59 radiographic progression 59 Postoperative complications 59 mesalamine granules 59 goserelin 59 systolic dysfunction 59 lower extremity amputation 59 concomitant AEDs 59 RBC transfusions 59 preintervention 59 carotid artery stenosis 59 postoperative infection 59 TEAEs 59 sternotomy 59 warfarin therapy 59 CC genotype 59 INCB# [003] 59 angioplasty stenting 59 ablative therapy 59 fine needle aspiration 59 Psoriasis Area 59 osteochondroma 59 endoscopic remission 59 serum PSA 59 QTc interval 59 cytogenetic responses 59 reinterventions 59 pegylated interferon alfa 2b 59 postoperative pulmonary 59 lamivudine monotherapy 59 cancer mCRC 59 pre cancerous polyps 59 proximal colon 59 esophagogastric 59 VCUG 59 functional mitral regurgitation 59 esophagogastroduodenoscopy 59 lipomas 59 metastatic castration resistant 59 thrombocytosis 59 varicocele 59 Coronary Artery Bypass Graft 59 Androgen deprivation therapy 59 colorectal neoplasms 59 surgical revascularization 59 hormone receptor negative 59 concomitant antibiotics 59 Lumpectomy 59 postsurgical 59 evaluable 59 microdebrider 59 histopathologic examination 59 artery stenosis 59 μmol L 59 adjunctive placebo 59 squamous cell carcinoma SCC 59 ERCP 59 electrical cardioversion 58 neurologic progression 58 systemic corticosteroid 58 neointimal hyperplasia 58 gastric adenocarcinoma 58 pathologic examination 58 atherosclerotic renal artery stenosis 58 nonalcoholic steatohepatitis NASH 58 nondiabetic patients 58 venous thrombosis 58 renal allograft 58 elevated IOP 58 premenopausal 58 TEVAR 58 neoplastic 58 thrombolytic therapy 58 laparotomy 58 endophthalmitis 58 ARB telmisartan 58 urate lowering therapy 58 urothelial cancer 58 cranial radiation 58 intraperitoneal chemotherapy 58 clopidogrel pretreatment 58 spontaneous bacterial peritonitis 58 microvascular disease 58 percutaneous transluminal coronary angioplasty 58 pelvic prolapse 58 Mitral Regurgitation 58 serum phosphate levels 58 ultrasonographic 58 oral clodronate 58 thrombotic complications 58 posttraumatic arthritis 58 microvascular complications 58 Combination therapy 58 hematopoietic cancers 58 glomerular filtration 58 comorbid conditions 58 penetrating keratoplasty 58 neoadjuvant HT 58 postoperative AF 58 invasive aspergillosis 58 precancerous cervical 58 cisplatin resistant 58 upper endoscopy 58 IPSS 58 serum testosterone 58 nonsurgical treatments 58 percutaneous drainage 58 pheochromocytoma 58 Adjuvant therapy 58 fallopian tube cancers 58 carotid surgery 58 preventive mastectomy 58 bladder cancers 58 heterotaxy 58 colorectal polyps 58 aortic insufficiency 58 FFR guided 58 graft dysfunction 58 neurofibromas 58 univariate analysis 58 levodopa therapy 58 infraspinatus 58 saphenous vein grafts 58 folinic acid 58 hemodialysis patients 58 daunorubicin 58 ORIF 58 chronic GVHD 58 adalimumab 58 performed laparoscopically 58 dual antiplatelet therapy 58 underwent CABG 58 baseline HbA1c 58 nonmelanoma skin cancer 58 post operatively 58 contralateral prophylactic mastectomy 58 radicular pain 58 anastrozole 58 Liver transplantation 58 renal parenchyma 58 ductal carcinomas 58 deferoxamine 58 del 5q MDS 58 MGUS 58 undetectable viral load 58 osteoporotic compression fractures 58 hepatorenal syndrome 58 thrombus aspiration 58 ABVD 58 ALA PDT 58 coronary angiogram 58 Flu Cy 58 lymphocytosis 58 ascites 58 anthracycline taxane 58 polyp detection 58 hip BMD 58 antireflux surgery 58 proliferative diabetic retinopathy 58 debulking 58 CABG surgery 58 EGFR mutation 58 oropharyngeal 58 malperfusion 58 transvaginal sonography 58 parathyroid 58 CP CPPS 58 transurethral 58 Hazard Ratio 58 nonischemic 58 remission CR 58 antiandrogen 58 KRAS mutation 58 Resection 58 intact parathyroid hormone 58 interferon alfa 2b 58 undetectable PSA 58 hyperplasia BPH 58 pituitary adenomas 58 chronic eosinophilic leukemia 58 sonographic findings 58 malabsorptive 58 KRAS status 58 primary percutaneous coronary 58 Squamous 58 Scale EDSS 58 TNF blocker therapy 58 prostate biopsy 58 wound dehiscence 58 inguinal hernia repair 58 CDI recurrence 58 lobular cancer 58 intracapsular 58 preoperative MRI 58 occult metastases 58 neoplastic lesions 58 renal transplants 58 immunosuppressive regimen 58 colorectal polyp 58 interferon alfa 2a 58 LV dysfunction 58 pre operatively 58 CK MB 58 screening colonoscopy 58 femoral neck fracture 58 conjunctival hyperemia 58 medullary thyroid cancer 58 mediastinal lymph nodes 58 neoplasms 58 angiographic outcomes 58 antibody titer 58 neoplasm 58 hamartoma 58 subependymal giant cell 58 Stent thrombosis 58 kidney cysts 58 Surgical excision 58 ureteroscopy 58 CIN3 + 58 normal karyotype 58 obstructive CAD 58 coronary intervention 58 LEXIVA r 58 carcinoid tumor 58 gastric corpus 58 ischemic lesions 58 A1c levels 58 NIHSS 58 urine cytology 58 left ventricular dysfunction 58 Torisel 58 BRCA mutation carriers 58 calculated creatinine clearance 58 hyperplastic polyps 58 STEMI patients 58 somatostatin analog 58 trimethoprim sulfamethoxazole 58 renal dysfunction 58 laryngectomy 58 colorectal cancer liver metastases 58 surgically resected 58 QTcF 58 tamoxifen Nolvadex ® 58 transarterial 58 NIHSS score 58 NNT = 58 NATRECOR ® 58 dacarbazine chemotherapy 58 digital rectal examination 58 coronary stenosis 58 concurrent chemoradiation 58 vWD 58 tapentadol ER 58 genotypic resistance 58 HER2 positive tumors 58 video assisted thoracoscopic 58 balloon valvuloplasty 58 uncorrected visual acuity 58 p# mutations 58 IM progesterone 58 leukopenia 58 hormonal therapy 58 hyperalgesia 58 nadroparin 58 metastatic malignant 58 arthrodesis 58 full thickness plication 58 serum clusterin levels 58 alanine aminotransferase ALT 58 bladder augmentation 58 thrombocytopenic 58 liver biopsy 58 anastomotic leak 58 ALT elevation 58 vinorelbine 58 DMARDs 58 cervical intraepithelial neoplasia 58 low dose Iluvien 58 cystoscopic 58 CABG 58 bivalirudin 58 #mmHg [001] 58 Events MACE 58 HbA1c levels 58 LHRH receptor positive 58 coronary angiography 58 epithelial ovarian cancer 58 carotid artery stent 58 histologies 58 portal vein thrombosis 58 histological subtype 58 fulvestrant 58 elevated transaminases 58 extracolonic findings 58 lipid lowering agents 58 advanced hepatocellular carcinoma